Combined electric and acoustic stimulation (EAS) of the auditory system is a new therapy for patients with severe to profound high- and mid-frequency hearing loss but remaining low-frequency hearing. In a prospective study, 13 patients with low-frequency hearing of better than 60 dB below 1 kHz were implanted with a MED-EL COMBI 40+ cochlear implant. Pure tone thresholds as well as monosyllabic word scores and Hochmair-Schulz-Moser sentences in quiet and in noise were measured with hearing aids, cochlear implant alone and in the combined stimulation mode (EAS) in the same ear. Hearing could be partially preserved in 11 out of the 13 patients. All patients scored significantly higher with cochlear implant alone than with hearing aids. Seven patients scored higher in the EAS mode than with cochlear implant alone for sentences in noise, 4 remained unchanged, and 2 could not use EAS. Synergistic effects of EAS were most prominent for hearing in noise with increases of up to 72% as compared to cochlear implant alone.

1.
Adunka O, Kiefer J, Unkelbach MH, Lehnert T, Gstoettner W: Development and evaluation of an improved cochlear implant electrode design for electric acoustic stimulation. Laryngoscope 2004;114:1237–1241.
2.
von Békésy G: Experiments in Hearing. New York, McGraw-Hill Book Company Inc, 1960.
3.
Brimacombe JA, Arndt PL, Staller SJ, Beiter AL: Multichannel cochlear implantation in adults with severe-to-profound sensorineural hearing loss; in Hochmair-Desoyer IJ, Hochmair E (eds): Advances in Cochlear Implant. Vienna, Manz, 1994, pp 387–392.
4.
Ching TYC, Dillon H, Byrne D: Speech recognition of hearing-impaired listeners: Predictions from audibility and the limited role of high-frequency amplification. J Acoust Soc Am 1998;103:128–140.
5.
Dorman MF, Spahr AC, Loizou PC, Dana CJ, Schmidt JS: Acoustic simulations of eombined electric and acoustic hearing (EAS). Ear Hear, in press.
6.
Fraysse B, Dillier N, Klenzner T, Laszig R, Manrique M, Morera Perez C, Morgon AH, Muller-Deile J, Ramos Macias A: Cochlear implants for adults obtaining marginal benefit from acoustic amplification: A European study. Am J Otol 1998;19:591–597.
7.
Gantz BJ, Turner CW: Combining acoustic and electric hearing. Laryngoscope 2003;113:2003:1726–1730.
8.
Greenwood DD: A cochlear frequency-position function for several species –29 years later. J Acoust Soc Am 1990;87:2592–2605.
9.
Gstoettner W, Adunka O, Hamzavi J, Lautischer M, Baumgartner W: Speech discrimination scores of postlingually deaf cochlear-implanted patients (in German). Wien Klin Wochenschr 2000;112:487–491.
10.
Hartmann R, Klinke: Response characteristics of nerve fibers to patterned electrical stimulation; in Miller JM, Spelman F (eds): Cochlear Implants, Models of the Electrically Stimulated Ear. New York, Springer, 1990, pp 135–160.
11.
Hartmann R, Topp G, Klinke R: Comparison of auditory single fiber responses during acoustic and electrical stimulation of the intact cat cochlea. Arch Otorhinolaryngol 1982;234:187–188.
12.
Helms J, Müller J, Schön F, Moser L, Arnold W, Janssen T, Ramsden R, von Ilberg C, Kiefer J, Pfennigdorff T, Gstoettner W, Baumgartner W, Ehrenberger K, Skarzynski H, Ribari O, et al: Evaluation of performance with the COMBI 40 cochlear implant in adults: A multicentric study. ORL J Otorhinolaryngol Relat Spec 1997;59:23–35.
13.
Hochmair I, Arnold W, Nopp P, Jolly C, Müller J, Roland P: Deep electrode insertion in cochlear implants: Apical morphology, electrodes and speech perception results. Acta Otolaryngol 2003;123:612–617.
14.
Hogan CA, Turner CW: High-frequency audibility: Benefits for hearing-impaired listeners. J Acoust Soc Am 1998;104:432–441.
15.
Honert C van den, Stypulkowski PH: Temporal response patterns of single auditory nerve fibers elicited by periodic electrical stimuli. Hear Res 1987;29:207–222.
16.
von Ilberg C, Kiefer J, Tillein J, Pfennigdorff T, Hartmann R, Stürzebecher E, Klinke R: Electric-acoustic stimulation of the auditory system. New technology for severe hearing loss. ORL 1999;61:334–340.
17.
Kiang NY-S, Watanabe T, Thomas EC, Clark LF: Discharge Patterns of Single Fibers in the Cats Auditory Nerve. Cambridge, MIT Press, 1965.
18.
Kiefer J, Gstoettner W, Baumgartner W, Pok SM, Tillein J, Ye Q, von Ilberg C: Conservation of low frequency hearing in cochlear implantation. Acta Otolaryngol 2004a;124:272–280.
19.
Kiefer J, von Ilberg C, Reimer B, Knech R, Gall V, Diller G, Stürzebecher E, Pfennigdorff T: Results of cochlear implantation in patients with severe to profound hearing loss – Implications for the indications. Audiology 1998;37:382–395.
20.
Kiefer J, Tillein J, von Ilberg C, Pfennigdorff T, Stürzebecher E, Klinke R, Gstöttner W: Fundamental aspects and first clinical results of the clinical application of combined electric and acoustic stimulation of the auditory system; in Kubo T, Takahashi Y, Iwaki T (eds): Advances in Cochlear Implants – An Update. The Hague, Kugler Publications, 2002, pp 569–576.
21.
Kiefer J, Tillein J, Ye Q, Klinke R, Gstoettner W: Application of carbon dioxide and erbium:yttrium-aluminum-garnet lasers in inner ear surgery – An experimental study. Otol Neurotol 2004b;25:400–409.
22.
Klenzner T, Stecker M, Marangos N, Laszig R: Extended indications for cochlear implantation. The Freiburg results in patients with residual hearing. HNO 1999;47:95–100.
23.
Klinke R, Hartmann R: Physiologische Grundlagen einer Hörprothese. Arch Otorhinolaryngol 1997;223:77–137.
24.
Lehnhardt E: Intracochlear placement of cochlear implant electrodes in soft surgery technique. HNO 1993;41:356–359.
25.
Otte J, Schuknecht HF, Kerr AG: Ganglion cell populations in normal and pathological human cochleae. Implications for cochlear implantation. Laryngoscope 1978:1231–1246.
26.
Skarzynski H, Lorens A, D’Haese P, Walkowiak A, Piotrowska A, Sliwa L, Anderson I: Preservation of residual hearing in children and post-lingually deafened adults after cochlear implantation: An initial study. ORL J Otorhinolaryngol Relat Spec 2002;64:247–253.
27.
Thorne M, Salt AN, DeMott JE, Henson MM, Henson OW Jr, Gewalt SL: Cochlear fluid space dimensions for six species derived from reconstructions of three-dimensional magnetic resonance images. Laryngoscope 1999;109:1661–1668 .
28.
Tillein J, Kral A, Vollmer M, Klinke R, Hartmann R: Results from EAS studies in the cat. Interaction between electric and acoustic responses (abstract). Hearing Preservation Workshop II, Frankfurt, October 2003, p 24.
29.
Tillein J, Vollmer M, Kral A, Klinke R, Hartmann R: Interactions between electrical and acoustical auditory nerve fiber responses of intracochlear implanted cats with residual hearing (abstract 565). ARO, New Orleans, 2004.
30.
Úhlehlová L, Voldřich L, Janisch R: Correlative study of sensory cell density and cochlear length in humans. Hear Res 1987;28:149–151.
31.
Wilson B, Wolford R, Lawson D, Schatzer R: Speech processors for auditory prosthesis. Third quarterly progress report (Oct–Dec 2002), NIH Project N01-DC-2-1002. NIH, 2003.
32.
Xu J, Shepherd RK, Millard RE, Clark GM: Chronic electrical stimulation of the auditory nerve at high stimulus rates: A physiological and histopathological study. Hear Res 1997;105:1–29.
33.
Zenner HP: Schwerhörigkeit und Tinnitus. Dtsch Ärztebl 1998;37:2361–2365.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.